Zynlonta
Australian Public Assessment Report
Device/Product Name
Zynlonta
Active ingredients
loncastuximab tesirine
AusPAR Date
Published
Sponsor
Submission Number
PM-2025-00489-1-4
Submission Type
New biological entity
Decision
Approved